3D Bioprinting for Engineered Tissue Constructs and Patient‐Specific Models: Current Progress and Prospects in Clinical Applications
Advanced Materials · 2024-12 · 36 (49)
DOI: 10.1002/adma.202408032 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 17.10.2024. Verfasst von Sang Jin Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA. Hauptthemen laut MEDLINE: Tissue Engineering, Printing, Three-Dimensional, Bioprinting, Tissue Scaffolds. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 352 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NICHD NIH HHS, NIH HHS.
Abstract (Originalsprache)
Advancements in bioprinting technology are driving the creation of complex, functional tissue constructs for use in tissue engineering and regenerative medicine. Various methods, including extrusion, jetting, and light‐based bioprinting, have their unique advantages and drawbacks. Over the years, researchers and industry leaders have made significant progress in enhancing bioprinting techniques and materials, resulting in the production of increasingly sophisticated tissue constructs. Despite this progress, challenges still need to be addressed in achieving clinically relevant, human‐scale tissue constructs, presenting a hurdle to widespread clinical translation. However, with ongoing interdisciplinary research and collaboration, the field is rapidly evolving and holds promise for personalized medical interventions. Continued development and refinement of bioprinting technologies have the potential to address complex medical needs, enabling the development of functional, transplantable tissues and organs, as well as advanced in vitro tissue models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
ORCID-Profile: Sang Jin Lee, Wonwoo Jeong, Anthony Atala
Förderung
- NIDCR NIH HHS
- NICHD NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Lee, S. J., Jeong, W., & Atala, A. (2024). 3D Bioprinting for Engineered Tissue Constructs and Patient‐Specific Models: Current Progress and Prospects in Clinical Applications. Advanced Materials, 36(49). https://doi.org/10.1002/adma.202408032
Vancouver
Lee SJ, Jeong W, Atala A. 3D Bioprinting for Engineered Tissue Constructs and Patient‐Specific Models: Current Progress and Prospects in Clinical Applications. Advanced Materials. 2024;36(49). doi:10.1002/adma.202408032
BibTeX
@article{Lee2024,
author = {Lee, Sang Jin and Jeong, Wonwoo and Atala, Anthony},
title = {3D Bioprinting for Engineered Tissue Constructs and Patient‐Specific Models: Current Progress and Prospects in Clinical Applications},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {49},
doi = {10.1002/adma.202408032}
}
EUVIMED